Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases.
about
Pharmacology of anabolic steroidsAnabolic-androgenic steroid dependence: an emerging disorderStudy Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)Effects of anabolic-androgens on brain reward functionThe impact of nandrolone decanoate on the central nervous systemMad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviorsCorticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.Anabolic androgenic steroid abuse: multiple mechanisms of regulation of GABAergic synapses in neuroendocrine control regions of the rodent forebrainChronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouseChronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouseThe Buzz about anabolic androgenic steroids: electrophysiological effects in excitable tissues.Effects of chronic exposure to an anabolic androgenic steroid cocktail on alpha5-receptor-mediated GABAergic transmission and neural signaling in the forebrain of female miceEffects of Strength Training and Anabolic Steroid in the Peripheral Nerve and Skeletal Muscle Morphology of Aged Rats.Illicit anabolic-androgenic steroid useCardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythmGraded inhibition of pulsatile luteinizing hormone secretion by a selective gonadotropin-releasing hormone (GnRH)-receptor antagonist in healthy men: evidence that age attenuates hypothalamic GnRH outflowAnalysis of androgenic steroids in environmental waters by large-volume injection liquid chromatography tandem mass spectrometry.Enobosarm (GTx-024, S-22): a potential treatment for cachexia.Anabolic steroids affect human periodontal health and microbiota.Effects of anabolic steroids and high-intensity aerobic exercise on skeletal muscle of transgenic mice.Sex hormonal regulation and hormesis in aging and longevity: role of vitagenesAnabolic-androgenic steroid use and psychopathology in athletes. A systematic reviewInfluence of nandrolone decanoate administration on serum lipids and liver enzymes in ratsAdvances in male hormone substitution therapy.Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism.Judging cheaters: is substance misuse viewed similarly in the athletic and academic domains?The role of androgens in hormone replacement therapy.National Athletic Trainers' Association position statement: anabolic-androgenic steroids.Testosterone and doping controlBiological augmentation of rotator cuff tendon repair.Health-related quality of life and physical functioning in people living with HIV/AIDS: a case-control design.Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trialSustained Administration of Hormones Exploiting Nanoconfined Diffusion through Nanochannel MembranesChronic exposure to anabolic androgenic steroids alters neuronal function in the mammalian forebrain via androgen receptor- and estrogen receptor-mediated mechanisms.Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention.Anemia of renal disease: what it is, what to do and what's new.Anabolic Actions of the Regenerative Agent Enamel Matrix Derivative (EMD) in Oral Periosteal Fibroblasts and MG 63 Osteoblasts, Modulation by Nicotine and Glutathione in a Redox EnvironmentMechanisms of anabolic androgenic steroid inhibition of mammalian epsilon-subunit-containing GABAA receptors.Effect of Megestrol Acetate and Testosterone on Body Composition and Hormonal Responses in COPD Cachexia.The side effects of hormonal therapy at the patients with prostate cancer
P2860
Q24650695-39550EA1-9290-4C80-8605-E14734C218B6Q24653466-E06C93FD-3D3D-44A4-BD66-1626D6F5034BQ26747940-86F84FAB-8E07-4C06-8237-3A759A11076DQ26785394-C757FC23-5385-4095-881D-720CC22B666DQ28087544-0CF9DF1C-C202-4F11-B315-842FB4815A78Q30364736-597BD5E9-807D-4365-B338-14AB51C8A1FEQ30419669-78139E91-AB9D-4660-8F5C-864FD6157A47Q30423173-E31C7B27-D91F-4B98-9991-DBC67FC2057CQ30425290-E3C98640-0534-4AE2-B219-B5349F6A86E0Q30430100-10E89519-0FCE-4E6E-B2E4-29603F64BE01Q30449339-8795838F-5651-42E6-8426-889E9ED06532Q30480886-37E61229-5647-4576-8B9C-58012FD63603Q33854418-A491A6CE-B1A0-418C-81C4-C092FD34E204Q33905686-E9CE3470-3DCC-4E50-8D40-DD3BAEA01EAAQ33952427-5F424013-F4DF-4372-AE9C-61333B1D38CEQ34049414-8B6D6CD5-109F-41D9-9B38-3DFE08DD211CQ34082106-B595B9B3-1EB2-4474-BE90-0E418CD16D79Q34401825-F64D4E55-5899-4DCF-A694-7FFE6DEC2818Q35039756-4DB7174D-FC62-456A-9EAF-52070B027EF8Q35049342-728153C2-5D22-4BCD-BC65-6AA7D3F50D1CQ35333484-CB1ABB8D-FCE7-47F8-B777-0DBDD674C470Q35710533-249F2334-6B92-4661-96CD-70A621E62ECEQ36122245-69E3E7AC-5A74-40CB-B57D-D8CFD2695EEDQ36221968-6EFDE7B4-E914-4136-B611-EBD01A06F909Q36222083-6D329388-0554-409E-91E7-224FDCC7AE17Q36243755-E41B8B86-E893-4968-94AF-62EF5AF43512Q36249910-6C282FE9-504D-4755-8CDE-41DBC67E7A2FQ36299949-7313A1D4-6FEC-4087-AC9F-52843B9487A5Q36518635-3073C339-E2BB-4E6E-B1B4-A15C956AB2C5Q36826189-55285A4A-7EDE-4A4F-A22B-55ACF0750A53Q36972700-D0DE6AB8-77B9-4E30-A195-B55E8E65C466Q36981247-9568A6B8-0453-4372-A2D1-B105E0E3A7DEQ36982405-20D84BC9-A581-4DF8-8344-369ED7342271Q37435655-14FA6FDE-75D9-4BC3-862C-B8ADFF5229FBQ37801534-7F779988-160E-41CE-B0D7-C015D94111D1Q37923100-C57AE368-CCDB-4D33-9F9A-4BB27242ACCFQ39873227-66754B58-E013-4ABE-87B8-2798CDB3A075Q40303556-627B1892-ECFB-4B7B-99D3-CD54F6AC549CQ41434170-DBB5BEC5-EFD5-40C7-8C1C-37A0CDAD3356Q41859896-68AE19EE-0115-464E-BBBD-519C9A245003
P2860
Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical review 138: Anabolic- ...... treatment of chronic diseases.
@ast
Clinical review 138: Anabolic- ...... treatment of chronic diseases.
@en
type
label
Clinical review 138: Anabolic- ...... treatment of chronic diseases.
@ast
Clinical review 138: Anabolic- ...... treatment of chronic diseases.
@en
prefLabel
Clinical review 138: Anabolic- ...... treatment of chronic diseases.
@ast
Clinical review 138: Anabolic- ...... treatment of chronic diseases.
@en
P2093
P356
P1476
Clinical review 138: Anabolic- ...... treatment of chronic diseases.
@en
P2093
P304
P356
10.1210/JCEM.86.11.7983
P407
P577
2001-11-01T00:00:00Z